Www.pbm.va.gov
In 2005, sildenafil was approved by the FDA for the treatment of PAH (WHO Group 1) to improve exercise ability.19 The formulation approved for the treatment of PAH (Revatio®) differs from that approved for the treatment of erectile dysfunction (Viagra®) in tablet strength only. ................
................
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.